title: Enzalutamide withdrawal syndrome: is there a rationale?
authors: Medical Oncology, 'Maggiore della Carità' University Hospital, Novara, Italy.
authors: Alessandra
authors: A
authors: Mosca
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000009:adverse effects / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide